Study number
|
Study name
|
Year
|
Outlook
|
expt.events
|
expt.n
|
ctrl.events
|
ctrl.n
|
---|
1
|
Rauws
|
1990
|
published
|
7
|
24
|
5
|
26
|
2
|
Graham
|
1991
|
published
|
4
|
53
|
10
|
52
|
3
|
Bayrerdorffer
|
1992
|
published
|
2
|
29
|
4
|
29
|
4
|
Hosking
|
1992
|
published
|
8
|
78
|
21
|
77
|
5
|
Bianchi Porro
|
1993
|
published
|
7
|
91
|
12
|
92
|
6
|
Hentschel
|
1993
|
published
|
1
|
52
|
3
|
52
|
7
|
Mantzaris
|
1993
|
published
|
5
|
17
|
8
|
16
|
8
|
Wang
|
1993
|
published
|
3
|
23
|
6
|
36
|
9
|
Lin
|
1994
|
published
|
0
|
21
|
2
|
21
|
10
|
Spinzi
|
1994
|
published
|
2
|
24
|
3
|
29
|
11
|
Bayrerdorffer
|
1995
|
published
|
4
|
136
|
12
|
128
|
12
|
Katoh
|
1995
|
published
|
0
|
27
|
1
|
25
|
13
|
Logan
|
1995
|
published
|
2
|
70
|
6
|
78
|
14
|
Pinero
|
1995
|
published
|
8
|
30
|
7
|
30
|
15
|
Sobhani
|
1995
|
published
|
7
|
59
|
15
|
60
|
16
|
Avsar
|
1996
|
published
|
2
|
23
|
10
|
22
|
17
|
Figueroa
|
1996
|
published
|
4
|
57
|
4
|
43
|
18
|
Harford
|
1996
|
published
|
36
|
127
|
25
|
69
|
19
|
Kato
|
1996
|
published
|
0
|
28
|
1
|
23
|
20
|
O'Morain
|
1996
|
published
|
9
|
102
|
15
|
106
|
21
|
Parente
|
1996
|
published
|
7
|
63
|
1
|
33
|
22
|
Porro
|
1996
|
published
|
2
|
17
|
9
|
15
|
23
|
Shirotani
|
1996
|
published
|
4
|
25
|
6
|
25
|
24
|
Bardhan
|
1997
|
published
|
4
|
141
|
6
|
74
|
25
|
Carpintero
|
1997
|
published
|
3
|
78
|
3
|
44
|
26
|
Pounder
|
1997
|
published
|
5
|
61
|
8
|
30
|
27
|
Graham
|
1998
|
negative
|
NA
|
77
|
NA
|
76
|
28
|
Schwartz
|
1998
|
positive
|
NA
|
292
|
NA
|
60
|
29
|
Kepecki
|
1999
|
negative
|
NA
|
39
|
NA
|
34
|
30
|
van Zanten
|
1999
|
very positive
|
NA
|
98
|
NA
|
48
|
31
|
Wong
|
1999
|
negative
|
NA
|
57
|
NA
|
57
|
32
|
Asaka
|
2001
|
positive
|
NA
|
205
|
NA
|
51
|
33
|
Mones
|
2001
|
positive
|
NA
|
42
|
NA
|
43
|
- expt.n: Sample size of the experimental treatment arm.
- ctrl.n: Sample size of the control/reference treatment arm.
- expt.events: Number of events occurring within the experimental treatment group.
- ctrl.events: Number of events occurring within the control/reference treatment group.